Merck settles suit over illegal Vioxx marketing 
Published: November 2, 2012
Tags: class action, false marketing, Merck, Missouri, prescription drugs, Vioxx, Vioxx class action
Merck & Co. has agreed to pay at least $39 million into a fund to settle a Missouri class action over the marketing of the anti-inflammatory drug Vioxx, according to a tentative settlement agreement.
Parents claim wrongful death due to energy drink
Published: October 26, 2012
Tags: California, Delaware, ENERGY DRINKS, false marketing, fraudulent concealment, Maryland, product liability, wrongful death
The parents of a 14-year-old girl have filed a wrongful death lawsuit alleging that the makers of the popular beverage Monster Energy were guilty of fraudulent concealment and negligence in marketing the drink to their child.
Company to pay $4.7 million to settle false marketing suit
Published: May 20, 2011
Tags: false advertising, false marketing, New Jersey, sales practices
Vonage Holdings Corp. has agreed to pay $4.75 million to settle a class action lawsuit that was filed in 2008 over the company’s marketing and sales practices.
Marketing suit against Nexium thrown out
By:
Sylvia Hsieh
Published: November 10, 2009
Tags: AstraZeneca, deceptive trade practices, false marketing, FDA, Nexium, Prilosec
Drug maker AstraZeneca can’t be sued for allegedly falsely marketing Nexium as “new” and “better” than Prilosec even though the two drugs were very similar, because the FDA approved its labeling, the Arkansas Supreme Court has ruled.
